Template:Hyperlipoproteinemia: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(7 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
|- bgcolor="LightGrey"
!
[[Lipoprotein disorders| Lipoprotein Disorders Main Page]]
|-
|-
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |


Line 6: Line 11:
|- bgcolor="LightGrey"
|- bgcolor="LightGrey"


|- bgcolor="Pink"
!
[[Hypercholesterolemia (patient information)|Hypercholesterolemia Patient Information]]
|-
!
!
|- bgcolor="Coral"
 
|- bgcolor="Pink"
!
!
[[Lipid disorders|Lipid Disorders Main Page]]
[[Hypertriglyceridemia (patient information)|Hypertriglyceridemia Patient Information]]
|-  
|-  
!
!


|- bgcolor="LightCoral"
|- bgcolor="Pink"
!
!
[[Hyperlipoproteinemia|Hyperlipoproteinemia Main Page]]
[[Hyperlipoproteinemia#Overview|Overview]]
|-  
|-  
!
!
Line 21: Line 32:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Hyperlipoproteinemia (patient information)|Patient Information]]
[[Hyperlipoproteinemia#Classification|Classification]]
:'''[[Familial hyperchylomicronemia]]'''
:'''[[Familial hypercholesterolemia]]'''
:'''[[Familial combined hyperlipidemia]]'''
:'''[[Dysbetalipoproteinemia]]'''
:'''[[Primary hypertriglyceridemia]]'''
:'''[[Mixed hyperlipoproteinemia]]'''
|-  
|-  
!
!
Line 27: Line 44:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Hyperlipoproteinemia#Overview|Overview]]
[[Hyperlipoproteinemia#Differential Diagnosis|Differential Diagnosis]]
|-  
|-  
!
!
Line 33: Line 50:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Hyperlipoproteinemia#Classification|Classification]]
[[Hyperlipoproteinemia#Screening|Screening]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="CadetBlue"
!
!
[[Hyperlipoproteinemia#Synopsis|Synopsis]]
'''ACC/AHA Guideline Recommendations'''
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
[[Hyperlipoproteinemia#Differential Diagnosis|Differential Diagnosis]]
[[ACC AHA guideline on summary of Key Recommendations for the Treatment of Blood Cholesterol to Reduce ASCVD Risk in Adults|Summary]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
[[Hyperlipoproteinemia#Diagnostic Algorithm|Diagnostic Algorithm]]
[[ACC AHA guideline on the treatment of blood cholesterol|Treatment]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
[[Hyperlipoproteinemia#Screening|Screening]]
[[ACC AHA guideline on the treatment of blood cholesterol statin treatment|Major recommendations for statin therapy]]
|-  
|-  
!
!


|- bgcolor="LightCoral"
|- bgcolor="PaleTurquoise"
!
!
'''Primary Hyperlipoprotein Disorders:'''
[[ACC AHA guideline on the treatment of blood cholesterol Managing Statin Therapy|Therapeutic response to statin therapy]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
:'''Type I - [[Familial hyperchylomicronemia]]'''
[[ACC AHA guideline on the treatment of blood cholesterol LDL and non-HDL treatment goals|Blood cholesterol LDL and non-HDL treatment goals]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
:'''Type II'''
[[ACC AHA guideline on the treatment of blood cholesterol heart failure and hemodialysis|Treatment in heart failure and hemodialysis]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
::'''Type IIA - [[Familial hypercholesterolemia]]'''
[[ACC AHA guideline on the treatment of blood cholesterol primary prevention|Primary prevention]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
::'''Type IIB - [[Familial combined hyperlipidemia]]'''
[[ACC AHA guideline on the treatment of blood cholesterol secondary prevention|Secondary prevention]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
:'''Type III - [[Dysbetalipoproteinemia]]'''
[[ACC AHA guideline on the treatment of blood cholesterol intensity of statin therapy in primary and secondary prevention|Intensity of statin therapy in primary and secondary prevention]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
:'''Type IV - [[Primary hypertriglyceridemia]]'''
[[ACC AHA guideline on the treatment of blood cholesterol safety|Safety Recommendations]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
:'''Type V - [[Mixed hyperlipoproteinemia]]'''
[[Lifestyle Management to Reduce Cholestrol|Guideline on Lifestyle Management]]
|-  
|-  
!
!
|}
|}

Latest revision as of 14:41, 3 March 2017